Sutureless 3F Enable Valve Replacement for Pure Aortic Regurgitation.

Area of Science:

• Cardiovascular Surgery
• Medical Devices
• Heart Valve Replacement

Background:

• Pure aortic regurgitation presents unique challenges for aortic valve replacement.
• Sutureless valve technology offers potential advantages in reducing procedure time and complications.

Purpose of the Study:

• To evaluate the feasibility and outcomes of using the Medtronic 3f Enable sutureless valve in patients with pure aortic regurgitation.
• To assess the technical aspects and early results of this specific valve implantation technique.

Main Methods:

• Retrospective analysis of 12 patients who received the sutureless valve for pure aortic regurgitation between March 2011 and February 2014.
• Procedures included full sternotomy, ministernotomy, and thoracoscopic approaches.
• Data collected on operative times, patient demographics, and early postoperative outcomes.

Main Results:

• Successful implantation of the sutureless valve in all 12 patients.
• Average cross-clamp and bypass times were 90 and 127 minutes, respectively.
• Mean follow-up of 11.1 months showed stable hemodynamics and no new paravalvular leakage; one initial patient had mild leakage.

Conclusions:

• The 3f Enable sutureless valve can be technically implanted in selected patients with pure aortic regurgitation.
• Further multicenter investigations are warranted to establish the mid-term efficacy and benefits of this device in this patient group.